563 related articles for article (PubMed ID: 34021229)
21. Efficacy of corticosteroids in non-intensive care unit patients with COVID-19 pneumonia from the New York Metropolitan region.
Majmundar M; Kansara T; Lenik JM; Park H; Ghosh K; Doshi R; Shah P; Kumar A; Amin H; Chaudhari S; Habtes I
PLoS One; 2020; 15(9):e0238827. PubMed ID: 32903258
[TBL] [Abstract][Full Text] [Related]
22. In-hospital survival of critically ill COVID-19 patients treated with glucocorticoids: a multicenter real-world data study.
Angermair S; Hardenberg JH; Rubarth K; Balzer F; Akbari N; Menk M; Spies C; Eckardt KU; Poddubnyy D; Siegmund B; Schneider T; Treskatsch S
Sci Rep; 2024 May; 14(1):12138. PubMed ID: 38802435
[TBL] [Abstract][Full Text] [Related]
23. Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study.
Moreno G; Rodríguez A; Reyes LF; Gomez J; Sole-Violan J; Díaz E; Bodí M; Trefler S; Guardiola J; Yébenes JC; Soriano A; Garnacho-Montero J; Socias L; Del Valle Ortíz M; Correig E; Marín-Corral J; Vallverdú-Vidal M; Restrepo MI; Torres A; Martín-Loeches I;
Intensive Care Med; 2018 Sep; 44(9):1470-1482. PubMed ID: 30074052
[TBL] [Abstract][Full Text] [Related]
24. Endotracheal intubation rate is lower with additional face-mask noninvasive ventilation for critically-ill SARS-CoV-2 patients requiring high-flow nasal oxygen: a retrospective bicentric cohort with propensity score analysis.
Urbina T; Elabbadi A; Gabarre P; Bigé N; Turpin M; Bonny V; Desnos C; Baudel JL; Lavillegrand JR; Hariri G; Fartoukh M; Guidet B; Maury E; Dumas G; Voiriot G; Ait-Oufella H
Minerva Anestesiol; 2022; 88(7-8):580-587. PubMed ID: 35191641
[TBL] [Abstract][Full Text] [Related]
25. Role of the early short-course corticosteroids treatment in ARDS caused by COVID-19: A single-center, retrospective analysis.
Boglione L; Olivieri C; Rostagno R; Poletti F; Moglia R; Bianchi B; Esposito M; Biffi S; Borrè S
Adv Med Sci; 2021 Sep; 66(2):262-268. PubMed ID: 34022675
[TBL] [Abstract][Full Text] [Related]
26. Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome.
Liu J; Zhang S; Dong X; Li Z; Xu Q; Feng H; Cai J; Huang S; Guo J; Zhang L; Chen Y; Zhu W; Du H; Liu Y; Wang T; Chen L; Wen Z; Annane D; Qu J; Chen D
J Clin Invest; 2020 Dec; 130(12):6417-6428. PubMed ID: 33141117
[TBL] [Abstract][Full Text] [Related]
27. Initial chest radiograph scores inform COVID-19 status, intensive care unit admission and need for mechanical ventilation.
Shen B; Hoshmand-Kochi M; Abbasi A; Glass S; Jiang Z; Singer AJ; Thode HC; Li H; Hou W; Duong TQ
Clin Radiol; 2021 Jun; 76(6):473.e1-473.e7. PubMed ID: 33706997
[TBL] [Abstract][Full Text] [Related]
28. Extended Versus Short-Course Corticosteroid Taper Regimens in the Management of Chronic Obstructive Pulmonary Disease Exacerbations in Critically Ill Patients.
Poon T; Paris DG; Aitken SL; Patrawalla P; Bondarsky E; Altshuler J
J Intensive Care Med; 2020 Mar; 35(3):257-263. PubMed ID: 29161935
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness and safety of favipiravir compared to supportive care in moderately to critically ill COVID-19 patients: a retrospective study with propensity score matching sensitivity analysis.
Alamer A; Alrashed AA; Alfaifi M; Alosaimi B; AlHassar F; Almutairi M; Howaidi J; Almutairi W; Mohzari Y; Sulaiman T; Al-Jedai A; Alajami HN; Alkharji F; Alsaeed A; Alali AH; Baredhwan AA; Abraham I; Almulhim AS
Curr Med Res Opin; 2021 Jul; 37(7):1085-1097. PubMed ID: 33890544
[TBL] [Abstract][Full Text] [Related]
30. Remdesivir for the treatment of COVID-19.
Ansems K; Grundeis F; Dahms K; Mikolajewska A; Thieme V; Piechotta V; Metzendorf MI; Stegemann M; Benstoem C; Fichtner F
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014962. PubMed ID: 34350582
[TBL] [Abstract][Full Text] [Related]
31. Clinical Use of Short-Course and Low-Dose Corticosteroids in Patients With Non-severe COVID-19 During Pneumonia Progression.
Hu Z; Lv Y; Xu C; Sun W; Chen W; Peng Z; Chen C; Cui X; Jiao D; Cheng C; Chi Y; Wei H; Hu C; Zeng Y; Zhang X; Yi Y
Front Public Health; 2020; 8():355. PubMed ID: 32719766
[No Abstract] [Full Text] [Related]
32. Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients: A Randomized Clinical Trial.
Ortigoza MB; Yoon H; Goldfeld KS; Troxel AB; Daily JP; Wu Y; Li Y; Wu D; Cobb GF; Baptiste G; O'Keeffe M; Corpuz MO; Ostrosky-Zeichner L; Amin A; Zacharioudakis IM; Jayaweera DT; Wu Y; Philley JV; Devine MS; Desruisseaux MS; Santin AD; Anjan S; Mathew R; Patel B; Nigo M; Upadhyay R; Kupferman T; Dentino AN; Nanchal R; Merlo CA; Hager DN; Chandran K; Lai JR; Rivera J; Bikash CR; Lasso G; Hilbert TP; Paroder M; Asencio AA; Liu M; Petkova E; Bragat A; Shaker R; McPherson DD; Sacco RL; Keller MJ; Grudzen CR; Hochman JS; Pirofski LA; ; Parameswaran L; Corcoran AT; Rohatgi A; Wronska MW; Wu X; Srinivasan R; Deng FM; Filardo TD; Pendse J; Blaser SB; Whyte O; Gallagher JM; Thomas OE; Ramos D; Sturm-Reganato CL; Fong CC; Daus IM; Payoen AG; Chiofolo JT; Friedman MT; Wu DW; Jacobson JL; Schneider JG; Sarwar UN; Wang HE; Huebinger RM; Dronavalli G; Bai Y; Grimes CZ; Eldin KW; Umana VE; Martin JG; Heath TR; Bello FO; Ransford DL; Laurent-Rolle M; Shenoi SV; Akide-Ndunge OB; Thapa B; Peterson JL; Knauf K; Patel SU; Cheney LL; Tormey CA; Hendrickson JE
JAMA Intern Med; 2022 Feb; 182(2):115-126. PubMed ID: 34901997
[TBL] [Abstract][Full Text] [Related]
33. Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia.
Pinzón MA; Ortiz S; Holguín H; Betancur JF; Cardona Arango D; Laniado H; Arias Arias C; Muñoz B; Quiceno J; Jaramillo D; Ramirez Z
PLoS One; 2021; 16(5):e0252057. PubMed ID: 34033648
[TBL] [Abstract][Full Text] [Related]
34. Impact of previous exposure to systemic corticosteroids on unfavorable outcome in patients hospitalized for COVID-19.
Lafaurie M; Martin-Blondel G; Delobel P; Kamar N; Charpentier S; Sommet A; Moulis G;
BMC Pharmacol Toxicol; 2021 Mar; 22(1):14. PubMed ID: 33706794
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of corticosteroid in patients with COVID-19: A multi-center retrospective study and meta-analysis.
Zhan Y; Shang J; Gu Y; Huang Q; Xie J
J Med Virol; 2021 Jul; 93(7):4292-4302. PubMed ID: 33666250
[TBL] [Abstract][Full Text] [Related]
36. Comparative Survival Analysis of Immunomodulatory Therapy for Coronavirus Disease 2019 Cytokine Storm.
Narain S; Stefanov DG; Chau AS; Weber AG; Marder G; Kaplan B; Malhotra P; Bloom O; Liu A; Lesser ML; Hajizadeh N;
Chest; 2021 Mar; 159(3):933-948. PubMed ID: 33075378
[TBL] [Abstract][Full Text] [Related]
37. Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak.
Wang Z; Wang Z
BMC Infect Dis; 2021 Jan; 21(1):113. PubMed ID: 33494706
[TBL] [Abstract][Full Text] [Related]
38. Do high-dose corticosteroids improve outcomes in hospitalized COVID-19 patients?
Kumar G; Patel D; Hererra M; Jefferies D; Sakhuja A; Meersman M; Dalton D; Nanchal R; Guddati AK
J Med Virol; 2022 Jan; 94(1):372-379. PubMed ID: 34559436
[TBL] [Abstract][Full Text] [Related]
39. Corticosteroids treatment in severe patients with COVID-19: a propensity score matching study.
Chen Q; Song Y; Wang L; Zhang Y; Han L; Liu J; Yang M; Ma J; Wang T
Expert Rev Respir Med; 2021 Apr; 15(4):543-552. PubMed ID: 33249945
[TBL] [Abstract][Full Text] [Related]
40. Timing of corticosteroids impacts mortality in hospitalized COVID-19 patients.
Bahl A; Johnson S; Chen NW
Intern Emerg Med; 2021 Sep; 16(6):1593-1603. PubMed ID: 33547620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
